Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03)

Publisher： Karger

E-ISSN： 2296-5262|33|6|295-299

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.6, 2010-05, pp. : 295-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

By Gelibter Alain J. Gamucci Teresa Pollera Camillo F. Di Costanzo Francesco Nuzzo Carmen Gabriele Angela Signorelli Carlo Gasperoni Silvia Ferraresi Virginia Giannarelli Diana Cognetti Francesco Zeuli Massimo

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2117-2123

Informa Healthcare

Access to resources Recommend Favorite

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 356-360

Karger

Access to resources Recommend Favorite

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 9-20

Karger

Access to resources Recommend Favorite

First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 353-357

Karger

Access to resources Recommend Favorite

Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)

Oncology, Vol. 85, Iss. 4, 2013-09 ,pp. : 208-215

Karger

Access to resources Recommend Favorite